The NIH is responsible for maintaining the public database of drug trial results, while the FDA is responsible for enforcing the statutory drug trial reporting requirements.
The law "was enacted in response to similar reporting failures that contributed to dangerous or ineffective drugs remaining on the market far longer than they should have," the letter points out. "The new study suggests this underreporting is continuing today."
The letter was signed by Reps. Henry Waxman (D-Calif.) and Edward MarkeyEd MarkeyOvernight Tech: GOP chairman to propose high-skilled visa overhaul | Zuckerberg's 5,700 word letter | Tech lobbies gear up ahead of internet fight Senate Dem blasts GOP for trying to repeal broadband privacy rules Judge orders release of EPA nominee’s emails MORE (D-Mass.), the top Democrats on the Energy and Commerce and Natural Resources committees, respectively, and Rep. Diana DeGette (D-Col.), ranking member on the Energy and Commerce oversight subpanel.